Clinical Trial Update: DHA-Paclitaxel in Treating Patients With Metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating DHA-paclitaxel in patients with metastatic prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DHA-paclitaxel

Snippet

Sponsor: Theradex | Conditions: Prostate Cancer | Phase 2 | Status: UNKNOWN